Allakos Operating Expenses 2011-2026 | ALLK

Annual Operating Expenses Allakos

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
196 M	322 M	271 M	157 M	91.4 M	45.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
322 M	45.7 M	181 M

Quarterly Operating Expenses Allakos

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.7 M	-	19.8 M	28.6 M	73.1 M	-	48.2 M	37.8 M	45 M	-	31.4 M	49.1 M	196 M	-	62.6 M	57.2 M	55.6 M	-	42.4 M	40.4 M	29.9 M	-	23.6 M	20.1 M	20.9 M	-	12 M	9.52 M	8.71 M	-	6.23 M	4.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
196 M	4.6 M	39.5 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Cerus Corporation CERS	149 M	$ 2.61	28.62 %	$ 497 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	512 M	$ 97.03	-6.21 %	$ 27.2 B	Germany
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Burford Capital Limited BUR	106 M	$ 5.17	5.08 %	$ 820 M	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 21.91	-2.41 %	$ 3.63 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Cardiff Oncology CRDF	49.6 M	$ 1.72	-0.87 %	$ 115 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Editas Medicine EDIT	201 M	$ 2.91	-3.0 %	$ 258 M	USA
Edesa Biotech EDSA	6.71 M	$ 17.35	-5.06 %	$ 55.5 M	USA
Dynavax Technologies Corporation DVAX	137 M	-	-	$ 2.02 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.03	-5.02 %	$ 4.99 M	Israel
Eiger BioPharmaceuticals EIGR	62.1 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	34.4 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Evogene Ltd. EVGN	13.8 M	$ 0.79	1.66 %	$ 27.9 M	Israel
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Galmed Pharmaceuticals Ltd. GLMD	32.9 M	$ 0.57	0.07 %	$ 2.46 M	Israel